The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 69 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Biomarkers, Tumor  [Clear All Filters]
2016
Fountzilas, G., Giannoulatou E., Alexopoulou Z., Zagouri F., Timotheadou E., Papadopoulou K., et al. (2016).  TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.. Oncotarget. 7(22), 32731-53.
Hatzibougias, D. I., Fouzas I., Bobos M., Papanikolaou V., Daoudaki M., Kotoula V., et al. (2016).  Tubular Pyloric Gland Adenoma of the Left and Right Hepatic Ducts: Report of a Unique Case With Immunohistochemical and Molecular Studies.. Int J Surg Pathol. 24(4), 347-52.
2015
Iliadis, A., Koletsa T., Kostopoulos I., & Tzioufa V. (2015).  Letter to the Editor: Diffuse TTF-1 expression in a case of Merkel cell carcinoma.. Pol J Pathol. 66(2), 200-1.
Carvajal-Hausdorf, D. E., Schalper K. A., Pusztai L., Psyrri A., Kalogeras K. T., Kotoula V., et al. (2015).  Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.. J Natl Cancer Inst. 107(8), 
Pavlakis, K., Bobos M., Batistatou A., Kotoula V., Eleftheraki A. G., Stofas A., et al. (2015).  p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumab.. Pathol Oncol Res. 21(2), 273-82.
2014
Lakis, S., Kotoula V., Eleftheraki A. G., Batistatou A., Bobos M., Koletsa T., et al. (2014).  The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.. Breast. 23(3), 234-43.
Dalamaga, M., Polyzos S. A., Karmaniolas K., Chamberland J., Lekka A., Migdalis I., et al. (2014).  Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study.. Biomarkers. 19(8), 660-6.
Tripsianis, G., Papadopoulou E., Anagnostopoulos K., Botaitis S., Katotomichelakis M., Romanidis K., et al. (2014).  Coexpression of IL-6 and TNF-α: prognostic significance on breast cancer outcome.. Neoplasma. 61(2), 205-12.
Vassilakopoulou, M., Togun T., Dafni U., Cheng H., Bordeaux J., Neumeister V. M., et al. (2014).  In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients.. PLoS One. 9(6), e99131.
Zarogoulidis, P., Katsikogianni F., Tsiouda T., Sakkas A., Katsikogiannis N., & Zarogoulidis K. (2014).  Interleukin-8 and interleukin-17 for cancer.. Cancer Invest. 32(5), 197-205.
Iakovou, I. P., & Giannoula E. (2014).  [Nuclear Medicine in diagnosis of breast cancer].. Hell J Nucl Med. 17(3), 221-7.
Koumarianou, A., Tzeveleki I., Mekras D., Eleftheraki A. G., Bobos M., Wirtz R., et al. (2014).  Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.. Anticancer Res. 34(9), 4949-62.
Krikelis, D., Kotoula V., Bobos M., Fountzilas E., Markou K., Karasmanis I., et al. (2014).  Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.. Anticancer Res. 34(11), 6495-503.
Konstantinidis, I. T., Do R. K. G., Gultekin D. H., Gönen M., Schwartz L. H., Fong Y., et al. (2014).  Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.. Ann Surg Oncol. 21(8), 2675-83.
Tsoulfas, G. (2014).  Role of microRNA in the diagnosis and therapy of hepatocellular carcinoma: a new frontier.. Microrna. 3(3), 137-43.
Vlachos, S., Tsaroucha A. K., Konstantoudakis G., Papachristou F., Trypsianis G., Schizas D., et al. (2014).  Serum profiles of M30, M65 and interleukin-17 compared with C-reactive protein in patients with mild and severe acute pancreatitis.. J Hepatobiliary Pancreat Sci. 21(12), 911-8.
2013
Dionysopoulos, D., Pavlakis K., Kotoula V., Fountzilas E., Markou K., Karasmanis I., et al. (2013).  Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.. Strahlenther Onkol. 189(3), 202-14.
Fountzilas, G., Dafni U., Bobos M., Kotoula V., Batistatou A., Xanthakis I., et al. (2013).  Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy.. BMC Cancer. 13, 163.
Fountzilas, E., Kotoula V., Angouridakis N., Karasmanis I., Wirtz R. M., Eleftheraki A. G., et al. (2013).  Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.. PLoS One. 8(8), e70429.
Fountzilas, G., Kotoula V., Pectasides D., Kouvatseas G., Timotheadou E., Bobos M., et al. (2013).  Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial.. PLoS One. 8(7), e69256.
Pantazopoulos, I., Xanthos T., Boura P., & Syrigos K. (2013).  Mesothelin and osteopontin.. Eur Respir J. 42(2), 557-8.
Michalopoulos, N., Pazaitou-Panayiotou K., Boudina M., Papavramidis T., Karayannopoulou G., & Papavramidis S. (2013).  Mixed corticomedullary adrenal carcinoma.. Surg Today. 43(11), 1232-9.
Kyrgidis, A., Athanassios K., Tzellos T-G., Trigoni A., & Triaridis S. (2013).  p16 post-hoc analyses and Simpson's paradox.. Lancet Oncol. 14(11), e436.
Kotoula, V., Kalogeras K. T., Kouvatseas G., Televantou D., Kronenwett R., Wirtz R. M., et al. (2013).  Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research.. Virchows Arch. 462(2), 141-54.
Tsalikidis, C., Papachristou F., Pitiakoudis M., Asimakopoulos B., Trypsianis G., Bolanaki E., et al. (2013).  Soluble E-cadherin as a diagnostic and prognostic marker in gastric carcinoma.. Folia Med (Plovdiv). 55(3-4), 26-32.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.